Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Hornung

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Blood|July 1, 1992
Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapyR L Hornung, D L Longo
Dermatology Nursing|October 1, 1992
Practical approaches to pediatric dermatologyR L Hornung, N S Prose
Pediatric Dermatology|February 14, 2002
Parental knowledge and practice of primary skin cancer prevention: gaps and solutionsJ M Weinstein, P R Yarnold, R L Hornung
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Systemic IL-1 and adjuvant treatment of an experimental tumor. I. Immune status following tumor rechallengeR L Hornung, S M Kiertscher, H L Mathews
Cancer Research|January 1, 1992
Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activityR L Hornung, J W Pearson, M Beckwith, et al.
Cancer Research|March 15, 1990
Correlation between in vivo induction of cytokine gene expression by flavone acetic acid and strict dose dependency and therapeutic efficacy against murine renal cancerK F Mace, R L Hornung, R H Wiltrout, et al.
Journal of the National Cancer Institute|October 5, 1988
Immunomodulation of natural killer cell activity by flavone acetic acid: occurrence via induction of interferon alpha/betaR L Hornung, H A Young, W J Urba, et al.
Journal of the National Cancer Institute|September 6, 1995
Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumorR L Hornung, D L Longo, O C Bowersox, et al.
Therapeutic Immunology|February 1, 1995
Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP)R L Hornung, D L Longo, V L Gowda, et al.
Cancer Research|December 15, 1990
Systemic alkalinization inhibits the ability of flavone acetic acid to augment natural killer activity, induce cytokine gene expression, and synergize with interleukin 2 for the treatment of murine renal cancerH Futami, R L Hornung, T T Back, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Blood|July 1, 1992
Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapyR L Hornung, D L Longo
Dermatology Nursing|October 1, 1992
Practical approaches to pediatric dermatologyR L Hornung, N S Prose
Pediatric Dermatology|February 14, 2002
Parental knowledge and practice of primary skin cancer prevention: gaps and solutionsJ M Weinstein, P R Yarnold, R L Hornung
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Systemic IL-1 and adjuvant treatment of an experimental tumor. I. Immune status following tumor rechallengeR L Hornung, S M Kiertscher, H L Mathews
Cancer Research|January 1, 1992
Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activityR L Hornung, J W Pearson, M Beckwith, et al.
Cancer Research|March 15, 1990
Correlation between in vivo induction of cytokine gene expression by flavone acetic acid and strict dose dependency and therapeutic efficacy against murine renal cancerK F Mace, R L Hornung, R H Wiltrout, et al.
Journal of the National Cancer Institute|October 5, 1988
Immunomodulation of natural killer cell activity by flavone acetic acid: occurrence via induction of interferon alpha/betaR L Hornung, H A Young, W J Urba, et al.
Journal of the National Cancer Institute|September 6, 1995
Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumorR L Hornung, D L Longo, O C Bowersox, et al.
Therapeutic Immunology|February 1, 1995
Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP)R L Hornung, D L Longo, V L Gowda, et al.
Cancer Research|December 15, 1990
Systemic alkalinization inhibits the ability of flavone acetic acid to augment natural killer activity, induce cytokine gene expression, and synergize with interleukin 2 for the treatment of murine renal cancerH Futami, R L Hornung, T T Back, et al.
Pageof 2